Clinical Trial Update: Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cetuximab as maintenance therapy after platinum-based first-line chemotherapy for non-small cell lung cancer has completed; results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Non-Small Cell Lung Cancer (NSCLC) | Phase 3 | Status: COMPLETED | Results posted: 2014-05-05